ATE269289T1 - Vitamin-d analoga - Google Patents

Vitamin-d analoga

Info

Publication number: ATE269289T1
Authority: AT; Austria
Prior art keywords: analogue; vitamin
Prior art date: 1999-11-24

Application number

AT00988868T

Other languages

English (en)

Inventor

Jean-Michel Bernardon

Thibaud Biadatti

Original Assignee

Galderma Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-24

Filing date

2000-11-22

Publication date

2004-07-15

2000-11-22 Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev

2004-07-15 Application granted granted Critical

2004-07-15 Publication of ATE269289T1 publication Critical patent/ATE269289T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/19—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to acyclic carbon atoms of the carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/26—Polyhydroxylic alcohols containing only six-membered aromatic rings as cyclic part
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Dermatology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Gerontology & Geriatric Medicine (AREA)
Cardiology (AREA)
Hematology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Birds (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Transplantation (AREA)
Ophthalmology & Optometry (AREA)
Nutrition Science (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT00988868T 1999-11-24 2000-11-22 Vitamin-d analoga ATE269289T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9914781A FR2801305B1 (fr)	1999-11-24	1999-11-24	Analogues de la vitamine d
PCT/FR2000/003249 WO2001038303A2 (fr)	1999-11-24	2000-11-22	Analogues de la vitamine d

Publications (1)

Publication Number	Publication Date
ATE269289T1 true ATE269289T1 (de)	2004-07-15

Family

ID=9552483

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00988868T ATE269289T1 (de)	1999-11-24	2000-11-22	Vitamin-d analoga

Country Status (22)

Country	Link
US (1)	US6831106B1 (de)
EP (1)	EP1235777B1 (de)
JP (1)	JP3822106B2 (de)
KR (1)	KR100599069B1 (de)
CN (2)	CN1213980C (de)
AR (1)	AR043279A1 (de)
AT (1)	ATE269289T1 (de)
AU (1)	AU767399B2 (de)
BR (1)	BR0015924A (de)
CA (1)	CA2392165C (de)
DE (1)	DE60011669T2 (de)
DK (1)	DK1235777T3 (de)
ES (1)	ES2223642T3 (de)
FR (1)	FR2801305B1 (de)
MX (1)	MXPA02005175A (de)
PL (1)	PL207046B1 (de)
PT (1)	PT1235777E (de)
RU (1)	RU2237651C2 (de)
SE (1)	SE1235777T5 (de)
TR (1)	TR200401603T4 (de)
WO (1)	WO2001038303A2 (de)
ZA (1)	ZA200203475B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6924400B2 (en) *	2001-12-10	2005-08-02	Galderma Research & Development, Snc	Triaromatic vitamin D analogues
FR2833258B1 (fr) *	2001-12-10	2004-08-27	Galderma Res & Dev	Analogues de la vitamine d
US7601850B2 (en) *	2002-05-29	2009-10-13	Eli Lilly And Company	Phenyl-thiophene type vitamin D receptor modulators
FR2843962B1 (fr) *	2002-08-27	2005-12-02	Galderma Res & Dev	Analogues de la vitamine d
AU2003267346B2 (en) *	2002-08-27	2010-06-24	Galderma Research & Development, S.N.C.	Analogues of vitamin D
WO2005027930A1 (en) *	2003-09-19	2005-03-31	Pfizer Products Inc.	2-alkylene-19-nor-vitamin d derivatives for the treatment of osteosarcoma
EP1952808A3 (de)	2003-11-21	2008-09-03	Galderma Research & Development	Zusammensetzung in Form eines Sprays enthaltend Calcitriol
DE602005021484D1 (de) *	2004-05-14	2010-07-08	Galderma Res & Dev	Neuartige 7,7-disubstituierte derivate von (5h,9h)-6,8-dioxabenzocyclohepten, herstellungsverfahren dafür und ihre verwendung in der synthese von nicht-steroidalen vitamin-d-analogen
FR2870238B1 (fr) *	2004-05-14	2008-07-04	Galderma Res & Dev	Nouveaux derives 7,7-disubstitues du (5h,9h)-6,8- dioxabenzocycloheptene, leur preparation et leur utilisation dans la synthese d'analogues non steroidiens de la vitamine d
CA2567099A1 (en) *	2004-05-26	2005-12-08	Cedars-Sinai Medical Center	Induction of innate immunity by vitamin d3 and its analogs
KR101225018B1 (ko) *	2004-09-02	2013-01-23	쿠리스 인코퍼레이션	헤지호그 신호전달에 대한 피리딜 억제제
FR2878245B1 (fr) *	2004-11-19	2007-02-16	Galderma Res & Dev	Nouveau procede de preparation du 3-(5'-(3,4-bis hydroxymethyl-benzyloxy)-2'-ethyl-2-propyl-biphenyl-4-yl)- penta-3ol
JP2008540514A (ja)	2005-05-10	2008-11-20	ダーミプソルリミテッド	過剰増殖表皮疾患の治療用組成物及び方法
AU2006245282A1 (en) *	2005-05-10	2006-11-16	Dermipsor Ltd.	Compositions and methods for skin care
JP5008928B2 (ja) *	2005-10-31	2012-08-22	三ツ星ベルト株式会社	プーリ構造体
WO2008083389A1 (en) *	2006-12-29	2008-07-10	Moleculin, L.L.C.	Methods of treating skin disorders with caffeic acid analogs
US8450337B2 (en) *	2008-09-30	2013-05-28	Moleculin, Llc	Methods of treating skin disorders with caffeic acid analogs
SG2014006324A (en)	2009-01-27	2014-03-28	Berg Llc	Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
US8470304B2 (en)	2009-08-04	2013-06-25	Avidas Pharmaceuticals Llc	Therapeutic vitamin D sun-protecting formulations and methods for their use
JP5978130B2 (ja)	2009-08-14	2016-08-24	バーグエルエルシー	脱毛症を治療するためのビタミンｄ３およびその類似体
CA2913543C (en)	2013-05-29	2024-01-09	Berg Llc	Preventing or mitigating chemotherapy induced alopecia using vitamin d
GB201705686D0 (en) *	2017-04-07	2017-05-24	Centauri Therapeutics Ltd	Novel compounds and therapeutic uses thereof
US11612580B2 (en)	2017-10-16	2023-03-28	The Board Of Regents Of The University Of Texas System	Compositions for inhibiting 3′ repair exonuclease 2 and methods of screening for such compositions
CN109738252B (zh) *	2019-01-23	2021-03-09	深圳天辰医疗科技有限公司	25-羟基-维生素d解离液
CN109696435B (zh) *	2019-01-25	2021-03-09	深圳天辰医疗科技有限公司	维生素d的测定方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ231735A (en) *	1988-12-23	1992-04-28	Ici Plc	Alcohol/ether derivatives, preparation and pharmaceutical compositions thereof
FR2713637B1 (fr) *	1993-12-15	1996-01-05	Cird Galderma	Nouveaux composés bi-aromatiques dérivés d'amide, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
WO1995027692A1 (en) *	1994-04-08	1995-10-19	Smithkline Beecham Corporation	Subtituted biphenyl tnf inhibitors
JPH08188650A (ja) *	1995-01-13	1996-07-23	Idemitsu Kosan Co Ltd	液晶共重合体の製造方法
FR2730995B1 (fr) *	1995-02-23	1997-04-04	Cird Galderma	Composes bi-aromatiques derives d'amide, compositions pharmaceutiques et cosmetiques les contenant et utilisations
WO1998020866A2 (en) *	1996-11-13	1998-05-22	Gill Parkash S	Method of treating kaposi's sarcoma by vitamin-d3 receptor agonists
FR2763588B1 (fr) *	1997-05-23	1999-07-09	Cird Galderma	Composes triaromatiques, compositions les contenant et utilisations
FR2776657B1 (fr) *	1998-03-31	2000-05-26	Cird Galderma	Composes bicycliques-aromatiques et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetologie
FR2776659B1 (fr) *	1998-03-31	2000-05-26	Cird Galderma	Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant
US6362371B1 (en) *	1998-06-08	2002-03-26	Advanced Medicine, Inc.	β2- adrenergic receptor agonists
US6274635B1 (en) *	1999-03-22	2001-08-14	Immugen Pharmaceuticals Inc.	Alkylated resorcinol derivatives for the treatment of immune diseases
US6442367B1 (en) *	1999-05-31	2002-08-27	Konica Corporation	Electrophotographic image forming method, electrophotographic image forming apparatus, and processing cartridge
US6683115B2 (en) *	1999-06-02	2004-01-27	Theravance, Inc.	β2-adrenergic receptor agonists
US6342642B1 (en) *	1999-11-09	2002-01-29	Basf Aktiengesellschaft	1,4-diaryl-2-fluoro-1-buten-3-ol compounds and their use in the preparation of 1,4-diaryl-2-fluoro-1,3-butadiene and 1,4-diaryl-2-fluoro-2-butene compounds

1999
- 1999-11-24 FR FR9914781A patent/FR2801305B1/fr not_active Expired - Fee Related
2000
- 2000-11-22 EP EP00988868A patent/EP1235777B1/de not_active Expired - Lifetime
- 2000-11-22 CA CA002392165A patent/CA2392165C/fr not_active Expired - Fee Related
- 2000-11-22 DK DK00988868T patent/DK1235777T3/da active
- 2000-11-22 MX MXPA02005175A patent/MXPA02005175A/es active IP Right Grant
- 2000-11-22 JP JP2001539859A patent/JP3822106B2/ja not_active Expired - Fee Related
- 2000-11-22 WO PCT/FR2000/003249 patent/WO2001038303A2/fr not_active Application Discontinuation
- 2000-11-22 AT AT00988868T patent/ATE269289T1/de active
- 2000-11-22 CN CNB008184585A patent/CN1213980C/zh not_active Expired - Fee Related
- 2000-11-22 DE DE60011669T patent/DE60011669T2/de not_active Expired - Lifetime
- 2000-11-22 PT PT00988868T patent/PT1235777E/pt unknown
- 2000-11-22 TR TR2004/01603T patent/TR200401603T4/xx unknown
- 2000-11-22 SE SE00988868T patent/SE1235777T5/xx unknown
- 2000-11-22 ES ES00988868T patent/ES2223642T3/es not_active Expired - Lifetime
- 2000-11-22 US US10/130,941 patent/US6831106B1/en not_active Expired - Fee Related
- 2000-11-22 CN CNB2004100789841A patent/CN100522943C/zh not_active Expired - Fee Related
- 2000-11-22 KR KR1020027006574A patent/KR100599069B1/ko not_active Expired - Fee Related
- 2000-11-22 BR BR0015924-7A patent/BR0015924A/pt active Search and Examination
- 2000-11-22 AU AU25222/01A patent/AU767399B2/en not_active Ceased
- 2000-11-22 RU RU2002116690A patent/RU2237651C2/ru not_active IP Right Cessation
- 2000-11-22 PL PL364768A patent/PL207046B1/pl not_active IP Right Cessation
- 2000-11-23 AR ARP000106191A patent/AR043279A1/es active IP Right Grant
2002
- 2002-05-02 ZA ZA200203475A patent/ZA200203475B/en unknown

Also Published As

Publication number	Publication date
AU2522201A (en)	2001-06-04
PL207046B1 (pl)	2010-10-29
JP3822106B2 (ja)	2006-09-13
FR2801305A1 (fr)	2001-05-25
DE60011669D1 (de)	2004-07-22
PL364768A1 (pl)	2004-12-13
DE60011669T2 (de)	2005-06-30
RU2237651C2 (ru)	2004-10-10
EP1235777A2 (de)	2002-09-04
WO2001038303A3 (fr)	2002-01-17
DK1235777T3 (da)	2004-09-20
PT1235777E (pt)	2004-11-30
CN1423627A (zh)	2003-06-11
CN100522943C (zh)	2009-08-05
CN1616452A (zh)	2005-05-18
KR100599069B1 (ko)	2006-07-12
CA2392165A1 (fr)	2001-05-31
WO2001038303A2 (fr)	2001-05-31
SE1235777T3 (de)	2004-08-03
JP2003514892A (ja)	2003-04-22
ZA200203475B (en)	2003-04-01
KR20020056944A (ko)	2002-07-10
BR0015924A (pt)	2002-08-06
TR200401603T4 (tr)	2004-08-23
ES2223642T3 (es)	2005-03-01
CA2392165C (fr)	2008-08-26
CN1213980C (zh)	2005-08-10
US6831106B1 (en)	2004-12-14
MXPA02005175A (es)	2003-01-28
EP1235777B1 (de)	2004-06-16
AU767399B2 (en)	2003-11-06
FR2801305B1 (fr)	2002-12-06
AR043279A1 (es)	2005-07-27
SE1235777T5 (de)	2004-09-21

Publication	Publication Date	Title
ATE269289T1 (de)	2004-07-15	Vitamin-d analoga
DE69923573D1 (de)	2005-03-10	Vitamin d-analoga
NO994094D0 (no)	1999-08-24	Stigerörsanordning
DE69935620D1 (de)	2007-05-03	Aufzug
PT1244641E (pt)	2005-08-31	Derivados da tiazolilamida
ATE262508T1 (de)	2004-04-15	Vitamin d3 analoga
PT1187814E (pt)	2004-10-29	Derivados da 5-fenil-pirimidina
ATA55499A (de)	2000-08-15	Zusammenlegbarer tretroller
NO20022606L (no)	2002-07-11	Farmasöytiske kombinasjoner
DK1235824T3 (da)	2004-06-28	D-vitaminanaloge forbindelser
ATE248122T1 (de)	2003-09-15	Beschleunigungsfahrsteig
DE69940408D1 (de)	2009-03-26	Rolltreppe
ATE455748T1 (de)	2010-02-15	Vitamin-d-analoga
DE69933927D1 (de)	2006-12-21	Absoluter wertkodierer
TR200002831A3 (tr)	2001-04-20	Kinolin-4-Il türevleri I
NO20015652L (no)	2002-01-14	1-trifluorometyl-4-hydroksy-7-piperidinyl- aminometylkromanderivater
DE60007483D1 (de)	2004-02-05	Aufzug
DE60110606D1 (de)	2005-06-09	16alpha-methyl oder ethyl substituierte oestrogene
DE60044316D1 (de)	2010-06-17	Modifizierte TIMPs
DE60010173D1 (de)	2004-06-03	Schlichtevorrichtung
SK2625U (sk)	2000-09-12	Hra
LV12223A (lv)	1999-02-20	Radioprotektorais arstniecibas lidzeklis
DE69933061D1 (de)	2006-10-12	Aufzug
ES1042207Y (es)	2000-01-16	Reloj analogico.
SE9901580D0 (sv)	1999-05-03	Trappa/ramp

Legal Events

Date	Code	Title	Description
2005-01-15	UEP	Publication of translation of european patent specification	Ref document number: 1235777 Country of ref document: EP

Date

Code

Title

Description

2005-01-15

UEP

Publication of translation of european patent specification

Ref document number: 1235777

Country of ref document: EP